Tumor-derived IL-6 may contribute to the immunological defect in CLL

• Published in: Leukemia Vol. 22; no. 5; pp. 1084 - 1087
• Main Authors: Buggins, A G S, Patten, P E M, Richards, J, Thomas, N S B, Mufti, G J, Devereux, S
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.05.2008; Nature Publishing; Nature Publishing Group
• Subjects: Biological and medical sciences; Cancer Research; Care and treatment; Chronic lymphocytic leukemia; Critical Care Medicine; Health aspects; Hematologic and hematopoietic diseases; Hematology; Humans; Immunology; Intensive; Interleukin 6; Interleukin-6 - immunology; Internal Medicine; letter-to-the-editor; Leukemia, Lymphocytic, Chronic, B-Cell - immunology; Leukemia, Lymphocytic, Chronic, B-Cell - pathology; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Medical sciences; Medicine; Medicine & Public Health; Neoplasm Proteins - immunology; Oncology; T-Lymphocytes - immunology; T-Lymphocytes - pathology; Tumors; United States; Interleukin 6; Chronic lymphocytic leukemia; Hematology; Lymphoproliferative syndrome; Cytokine; Tumor; Malignant hemopathy; Cancer